Analysis of molecular mechanisms in cystic fibrosis (CF) and X-linked myotubular myopathy (XLMTM) patients.

assignment_turned_inproject01 Jan 1999(Started)-31 Mar 2002(Ended)Closed

Funder: Swiss National Science FoundationProject code: 55697

Funded under: Projects | Project funding Funder Contribution: 410,000

Analysis of molecular mechanisms in cystic fibrosis (CF) and X-linked myotubular myopathy (XLMTM) patients.

- Summary
- DMPs

Partners

UB , University Hospital of Bern

Data Management Plans

Start a new DMP in Argos

Found an issue? Give us feedback

Select content type to embed

All Research products

arrow_drop_down

<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=snsf________::6f9ac0bcf8a6b1ae9e64d3df6f56d8e2&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Analysis of molecular mechanisms in cystic fibrosis (CF) and X-linked myotubular myopathy (XLMTM) patients.

Analysis of molecular mechanisms in cystic fibrosis (CF) and X-linked myotubular myopathy (XLMTM) patients.

Loading